HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.

AbstractBACKGROUND AND AIM:
Elevated serum phosphate and calcium-phosphate levels play an important role in the pathogenesis of vascular calcifications in uraemic patients and appear to be associated with increased cardiovascular mortality. We aimed to evaluate the effects of a partial replacement of food protein with a low-phosphorus and low-potassium whey protein concentrate on phosphate levels of dialysis patients with hyperphosphataemia.
METHODS AND RESULTS:
Twenty-seven patients undergoing chronic haemodialysis were studied for a 3-month period. In the intervention group (n = 15), food protein were replaced by 30 or 40 g of low-phosphorus and low-potassium protein concentrate aimed at limiting the phosphate intake. In the control group (n = 12) no changes were made to their usual diet. Anthropometric measurements, biochemical markers and dietary interviews were registered at baseline and during the follow-up period. From baseline to the end of the study, in the intervention group, serum phosphate and circulating intact parathyroid hormone levels lessened significantly (8.3 ± 1.2 mg/dL vs 5.7 ± 1.4 mg/dL and 488 ± 205 pg/ml vs 177 ± 100 pg/ml respectively; p < 0.05) with decreasing of phosphate and potassium intake. No significant differences were found in the control group. No significant changes were observed in serum albumin, calcium, potassium, Kt/V, body weight and body composition in both the intervention and control groups.
CONCLUSION:
Dietary intake of phosphate mainly comes from protein sources, so dietary phosphorus restriction may lead to a protein/energy malnutrition in a dialysis patient. A phosphorus-controlled diet plan including a nutritional substitute resulted in serum phosphate and intact parathyroid hormone decrease without nutritional status modifications in dialysis patients.
AuthorsB Guida, A Piccoli, R Trio, R Laccetti, A Nastasi, A Paglione, A Memoli, B Memoli
JournalNutrition, metabolism, and cardiovascular diseases : NMCD (Nutr Metab Cardiovasc Dis) Vol. 21 Issue 11 Pg. 879-84 (Nov 2011) ISSN: 1590-3729 [Electronic] Netherlands
PMID20609572 (Publication Type: Journal Article)
CopyrightCopyright © 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Dietary Proteins
  • Milk Proteins
  • Parathyroid Hormone
  • Phosphates
  • Phosphorus, Dietary
  • Potassium, Dietary
  • Whey Proteins
Topics
  • Diet
  • Dietary Proteins (administration & dosage, analysis)
  • Female
  • Humans
  • Hyperphosphatemia (diet therapy, etiology)
  • Male
  • Middle Aged
  • Milk Proteins (administration & dosage)
  • Parathyroid Hormone (blood)
  • Phosphates (blood)
  • Phosphorus, Dietary (administration & dosage)
  • Potassium, Dietary (administration & dosage)
  • Renal Dialysis
  • Uremia (therapy)
  • Whey Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: